OMAHA, Neb., Aug. 10 /PRNewswire-FirstCall/ -- Transgenomic Inc. announces the following Webcast:
What: Transgenomic Inc. Second Quarter 2006 Earnings Release Conference Call When: Thursday, August 10, 2006 @ 5:00 p.m. Eastern Where: http://www.transgenomic.com/events.asp?id=6 How: Live over the Internet -- Simply log on to the web at the address above. Contact: Investor Relations, 402-452-5400
To access the call via telephone, call 800-903-0258 or 785-832-2422. A replay of the call will be available via the telephone until 11:59 pm ET on August 24, 2006. To access, dial 800-839-4012 or 402-220-2981.
About Transgenomic
Transgenomic is a global biotechnology company that provides unique products and services for automated high sensitivity genetic variation and mutation analysis. Their offerings include systems, products, discovery and laboratory testing services to the academic and medical research, clinical laboratory and pharmaceutical markets in the fields of pharmacogenomics and personalized medicine. Specific offerings include Wave(TM) DHPLC systems, reagents, consumables and assay kits, Hanabi automated cytogenetics systems, and Transgenomic Discovery and CLIA Lab Services. To date there have been over 1,200 Wave systems installed in over 600 customer sites in over 35 countries and approximately 1,500 publications utilizing Transgenomic products or services. Transgenomic Discovery and Lab Services utilize their technology and expertise to provide a menu of mutation scanning tests for over 700 cancer-associated genes and more than 60 validated diagnostic tests to meet the needs of pharmaceutical and biotech companies, research and clinical laboratories, physicians and patients. For more information about the innovative systems, products and services offered by Transgenomic, please visit: www.transgenomic.com.
Transgenomic Inc.
CONTACT: Investor Relations, Transgenomic Inc., +1-402-452-5400
